Navigation Links
Nile Therapeutics Reports 2011 Third Quarter Financial Results
Date:11/14/2011

Part C, 12 patients received a 24-hour continuous subcutaneous infusion of either a weight-based dose of cenderitide, or placebo. All infusions were delivered through Medtronic, Inc.'s subcutaneous pump technology. Nile plans to announce top-line data from the clinical trial in November 2011, and intends to present the complete data at an upcoming scientific conference.

About Heart FailureHeart failure is the fastest-growing clinical cardiac disease in the U.S. according to the American Heart Association, affecting over 5 million Americans. Over 1 million patients in the U.S. each year are hospitalized with ADHF, an acute exacerbation of heart failure. ADHF is the is the most frequent cause of hospital admission in the U.S. for patients older than 65 years, generating annual inpatient costs of more than $35 billion. Within 90 days following admission for ADHF, approximately 40% of patients return to the hospital. Nile believes that a decrease in the ADHF re-hospitalization rate, which is the clinical target of the cenderitide development program, could both improve the quality of life for patients and decrease the annual inpatient cost of heart failure.

About Nile TherapeuticsNile Therapeutics, Inc. is a biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs. Nile is focusing its efforts on developing its lead compound, cenderitide, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure. The cenderitide program was granted Fast Track status by the United States Food and Drug Administration. More information on Nile can be found at http://www.nilethera.com.Safe Harbor Paragraph for Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
2. Orexigen® Therapeutics Reports Third Quarter Financial Results
3. Silence Therapeutics Provides Corporate and Development Update
4. Halozyme Therapeutics Reports Third Quarter 2011 Financial Results
5. Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System at the Transcatheter Cardiovascular Therapeutics (TCT) Symposium 2011
6. Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors of Nuclear Export (SINE) for Cancer
7. Halozyme Therapeutics Announces Data From Two Phase 1 Studies of PEGPH20 Demonstrating Targeting of Hyaluronan in Tumor Stroma
8. United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
9. Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline
10. Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
11. DLVR Therapeutics Inc. Raises Additional Capital Adding MaRS Innovation to Investor Base
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014 Research ... "Global and China Gel Permeation Chromatography (GPC) Industry ... The Global and China Gel Permeation Chromatography (GPC) ... the current state of the global gel permeation chromatography ... The report provides a basic overview of the industry ...
(Date:8/22/2014)... Toronto, Canada (PRWEB) August 22, 2014 ... traits in model organisms can be accelerated by ... design and manufacturing technologies, the custom SeqCap EZ ... such research. , Mr. Watson will additionally present ... seen with commercially available human and mouse exome ...
(Date:8/21/2014)... Finnish-Swedish research group at the Institute for Molecular ... institutet, Stockholm, has developed a novel "man and ... This innovative diagnostic aid was described in ... The method is based on computer vision algorithms ... combined with visualization of only the diagnostically most ...
(Date:8/21/2014)... IA (PRWEB) August 21, 2014 His ... LIBERTY Opening , The Court of His Majesty Willem-Alexander, ... will attend the Grand Opening of POET-DSM Advanced Biofuels’ ... Wednesday, Sept. 3. , The King will take part ... opening activity, scheduled for 11 a.m.-12:20 p.m. and tour ...
Breaking Biology Technology:Global and China Gel Permeation Chromatography (GPC) Industry Report 2014 2Efficient Identification of Protein-Coding Variants in a Model Organism Through Exome Sequencing, New Webinar Hosted by Xtalks 2A novel 'man and machine' decision support system makes malaria diagnostics more effective 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3
... ... ... ... ...
... ... ... ... ...
... ... ... ... ...
Cached Biology Technology:Volcano Corporation Presentation at Roth Capital Partners Conference to be Webcast 2Volcano Corporation Presentation at Roth Capital Partners Conference to be Webcast 3Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study 2Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study 3Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study 4Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study 5WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 2WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 3WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 4WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 5WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 6WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 7WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 8WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 9WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 10WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 11WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 12WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 13WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 14WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 15WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 16WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 17WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 18WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 19WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 20WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 21WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 22WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 23WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 24WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 25WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 26WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 27WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 28WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results 29
(Date:8/21/2014)... significant reduction in smog-producing toxins in past decade, ... new study shows that while the Greater Toronto ... toxins that contribute to smog, the city continues ... pollution., Smog, which can cause or aggravate health ... is produced by a set of complex photochemical ...
(Date:8/21/2014)... and other itchy, flaky maladies in humans has now ... reefs and the extreme environments of arctic soils and ... journal PLOS Pathogens considers the diversity, ecology, ... Malassezia in light of new insights gained from ... University of Hawai,i at Mānoa scientist Anthony Amend discovered ...
(Date:8/21/2014)... the Fram Strait is a key region in the global ... Greenland and Svalbard warm Atlantic water flows to the north ... Arctic water masses and sea ice push their way out ... of the Atlantic water cools here on its way to ... the water caused in this manner drives the global band ...
Breaking Biology News(10 mins):Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2From dandruff to deep sea vents, an ecologically hyper-diverse fungus 2Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3
... is available in German . , They ... species can still be found all over the world: mosses, ... Chemical Ecology in Jena, Germany, have now found out that ... volatiles when they are attacked − unlike many of the ...
... of Science Education and Technology G. Michael Barnett has ... by the Carnegie Foundation for the Advancement of Teaching ... (CASE) in recognition of his teaching excellence and positive ... is the only national program that recognizes excellence in ...
... viruses are particularly adept at defeating antiviral drugs because ... With at least one error in every genome they ... creating resistant mutants as they multiply. In the best-known ... to corner HIV and narrow its escape route. ...
Cached Biology News:Herbivore defense in ferns 2Herbivore defense in ferns 3Michael Barnett of Boston College named Professor of the Year for Massachusetts 2More than a machine 2
... Precision-designed for Optimal Microdissection , CapSure HS ... precise and rapid extraction of populations of ... samples with Laser Capture Microdissection., Ensure ... Molecular Analysis , All CapSure LCM Caps ...
... Microdissection , CapSure HS and CapSure Macro ... extraction of populations of pure cells from ... Capture Microdissection., Ensure the Integrity of ... All CapSure LCM Caps have a patented ...
... Precision-designed for Optimal Microdissection , CapSure ... the precise and rapid extraction of populations ... cytology samples with Laser Capture Microdissection., ... Downstream Molecular Analysis , All CapSure LCM ...
... Microdissection , CapSure HS and CapSure Macro ... extraction of populations of pure cells from ... Capture Microdissection., Ensure the Integrity of ... All CapSure LCM Caps have a patented ...
Biology Products: